Skip to main content
. 2023 Jun 22;12(13):4213. doi: 10.3390/jcm12134213

Table 2.

Procedural and clinical outcomes of the matched cohort.

Matched Cohort
Myval
n = 91
N (%) or Mean ± SD

Evolut
n = 91
N (%) or Mean ± SD
p-Value
Procedural details
Transfemoral approach 82 (90) 87 (96) 0.15
Transapical approach 9 (10) 0 (0) NA
Direct aortic approach 0 (0) 4 (4) NA
Predilation 4 (4) 23 (25) 0.0001
Postdilation 3 (3) 24 (26) <0.00001
Second valve prosthesis required 1 (1) 1 (1) 1.00
Procedural complications
Valve embolization 1 (1) 1 (1) 1.00
Annular rupture 0 (0) 0 (0) NA
Coronary obstruction 1 (1) 2 (2) 0.56
Procedural death 2 (2) 1 (1) 0.56
30-day outcomes
All-cause death 3 (3) 2 (2) 0.65
Cardiac death 1 (1) 2 (2) 0.56
All stroke 2 (2) 4 (4) 0.41
Myocardial infarction 1 (1) 3 (3) 0.31
Acute kidney injury (2 or 3) 5 (5) 6 (7) 0.76
Moderate or severe paravalvular leakage 1 (1) 4 (4) 0.17
New permanent pacemaker implantation 4 (4) 14 (15) 0.01
Major vascular complications 0 (0) 0 (0) NA
Major bleeding complications 0 (0) 0 (0) NA
1-year outcomes
All-cause death 8 (9) 7 (8) 0.79
Cardiac death 2 (2) 4 (4) 0.41
All stroke 6 (7) 5 (5) 0.76
Myocardial infarction 2 (2) 4 (4) 0.41